Calcium Acetate
NDC 16571-813, Calcium Acetate, capsule, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-813
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211038
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-813 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CALCIUM ACETATE667 mg/1
Pharmacologic classes
Blood Coagulation Factor [EPC]; Calcium [CS]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-813-20 | 16571081320 | 200 CAPSULE in 1 BOTTLE, PLASTIC (16571-813-20) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ce650ba5-fb42-e444-e053-2a95a90a075aNADAC price for package 16571081320
GET /v1/drugs/nadac/16571081320
Use it
Look up 16571-813 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-813 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-813. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.